Add BrightSurf on Google Email

Blood test may help identify which colon cancer patients benefit from NSAIDs

A blood test may help doctors identify which patients with colon cancer can benefit from anti-inflammatory medication and chemotherapy after surgery. The test measures circulating tumor DNA levels, and high-risk patients who test positive see improved survival rates when taking celecoxib with chemotherapy.

SourceAlliance for Clinical Trials in Oncology·JournalJAMA Oncology·TypeRandomized controlled/clinical trial·DateDec 15, 2025

Rangsit University study shows simple bypass protocol improves outcomes in chronic cerebral occlusion

A study from Rangsit University shows that a simple bypass protocol guided by mean transit time can improve symptoms in 80% of patients with chronic cerebral occlusion or moyamoya disease. The protocol uses non-stress testing to evaluate cerebrovascular reserve and predict postoperative improvement.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeObservational study·DateDec 12, 2025

FDA drug trials exclude a widening slice of Americans

A study found that only 6% of FDA-approved drugs reflect the US racial and ethnic makeup, with a decline in Black and Hispanic enrollment between 2021 and 2023. The researchers recommend setting diversity goals at preclinical stages and collecting biological samples to understand how people's bodies react to medications.

SourceUniversity of California - Riverside·JournalCommunications Medicine·DateDec 12, 2025
Sky & Telescope Pocket Sky Atlas, 2nd Edition

Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A new study presented at ASH 2025 suggests that a virtual program focusing on diet and exercise can help reduce the severity of side effects associated with lymphoma treatment. The program, LIFE-L, showed significant improvements in symptoms such as anxiety, depression, pain, fatigue, and constipation among participants.

SourceUniversity of Miami Miller School of Medicine·DateDec 7, 2025

UCF receives grant to address need for primary care physicians

The program provides financial aid and unique clinical experiences to medical students, encouraging them to become community physicians. UCF College of Medicine hopes the program can be used as a national model to address the nation's primary care physician shortage.

SourceUCF College of Medicine·DateDec 5, 2025
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Conquer the diseases of aging and humans could live far longer than we think, scientists propose

Researchers argue that widely used proxies for aging may conflate genuine modifications with simpler effects on physiology. Targeting specific pathologies can extend lifespan without slowing aging process. Historically, increased human lifespan was primarily driven by reduced infectious disease mortality, not a fundamental slowing of a...

SourceGenomic Press·JournalGenomic Psychiatry·TypeLiterature review·DateDec 2, 2025
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

New research confirms HPV vaccination prevents cervical cancer

Two new Cochrane reviews show that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus. Girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer.

SourceCochrane·JournalCochrane Database of Systematic Reviews·TypeSystematic review·DateNov 23, 2025

Do all countries benefit from clinical trials? A new Yale study examines the data

A new Yale study found that only 24% of medicines tested in clinical trials received market authorization, highlighting a significant 'test it but don't sell it' problem. The study highlights the need for collective effort from pharma companies, countries, and other stakeholders to improve post-trial access to life-saving medicines.

SourceYale University·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateNov 17, 2025
Aranet4 Home CO2 Monitor

Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.

Root canal treatment reduces heart disease and diabetes risk

A study published in Journal of Translational Medicine found that successful root canal treatment can reduce inflammation linked to heart disease and improve levels of blood sugar and cholesterol. The researchers discovered a link between monitoring blood metabolic markers after dental treatment, which could help assess recovery and risk.

SourceKing's College London·JournalJournal of Translational Medicine·DateNov 17, 2025

Human genetics study: Changes in a single gene can cause mental illness

A recent study found that changes in a single gene can cause mental illnesses, with the GRIN2A gene identified as a key culprit. Variants of this gene are associated with schizophrenia and other mental disorders, which can manifest in childhood or adolescence rather than adulthood.

SourceUniversität Leipzig·JournalMolecular Psychiatry·TypeData/statistical analysis·DateNov 14, 2025

Clinical trial in Africa finds single-dose malaria treatment combining four existing drugs as effective as more onerous multi-day, multi-dose regimen

A clinical trial in Africa has discovered a single-dose treatment combining sulfadoxine, pyrimethamine, artesunate, and pyronaridine (SPAP) that is as effective as traditional multi-day treatments in curing uncomplicated malaria. The study addresses the growing threat of drug-resistant malaria parasites and improves treatment adherence.

SourceAmerican Society of Tropical Medicine & Hygiene·DateNov 12, 2025
Sony Alpha a7 IV (Body Only)

Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.

Scientists move closer to better pancreatic cancer treatments

Researchers at UC Riverside and City of Hope have developed a novel Pin1 degrading compound that suppresses pancreatic cancer peritoneal metastases. The treatment targets not only cancer cells but also tumor-supporting cells, potentially overcoming treatment resistance.

SourceUniversity of California - Riverside·JournalMolecular Therapy Oncology·TypeExperimental study·DateNov 12, 2025

Chinese Neurosurgical Journal study compares carotid plaque composition in patients from China and US

Researchers analyzed carotid plaque samples from 75 Chinese and 111 US patients, revealing distinct differences in plaque morphology, size, and composition. The study highlights the importance of understanding population-specific variations to develop personalized treatment approaches for cerebrovascular events.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeImaging analysis·DateNov 11, 2025

How to identify and prevent fraudulent participants in health research

Researchers can utilize a combination of automated and manual actions to quickly identify suspicious behavior and prevent fraudulent actors from enrolling in online studies. A comprehensive checklist of indicators helps researchers spot potential fraud, such as similar patterns in email addresses or predictable responses.

SourceBoston University School of Public Health·JournalJournal of Medical Internet Research·TypeCase study·DateNov 5, 2025

Reducing reliance on corticosteroids with rituximab: renewed hope for adult-onset patients with relapsing nephrotic syndrome

A randomized clinical trial has shown that rituximab is effective in preventing relapses and reducing the need for corticosteroids in adults with relapsing nephrotic syndrome. The study involved 66 adult patients treated with either rituximab or a placebo, with impressive results at the 49-week follow-up.

SourceThe University of Osaka·JournalJAMA·TypeRandomized controlled/clinical trial·DateNov 5, 2025
Nikon Monarch 5 8x42 Binoculars

Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.

Louisiana Environmental influences on Child Health Outcomes, ECHO, Collaboration secures federal funding renewal

The Louisiana ECHO program, which focuses on pre-, peri- and postnatal outcomes, obesity, and other areas, will continue its efforts to expand access to clinical trials for Louisiana children. The grant renewal supports the collaboration between researchers from Pennington Biomedical and Ochsner Health System, as well as two free-stand...

SourcePennington Biomedical Research Center·DateNov 3, 2025

New dry macular degeneration treatment the first to halt disease’s progression

Researchers at Aalto University have developed a promising new treatment approach for dry age-related macular degeneration (AMD), which can potentially stop the disease's progression. The novel method uses heat and near-infrared light to trigger healing responses at a cellular level, strengthening protective mechanisms of affected cells.

SourceAalto University·JournalNature Communications·DateOct 30, 2025

The future is decentralized: Expanding clinical trials from home

New tools, such as CheatBlocker and QuotaConfig, help address challenges of data integrity in decentralized clinical trials. CheatBlocker detects fraud, while QuotaConfig ensures sample representativeness. These innovations aim to increase the reliability and security of remote clinical trials.

SourceMedical University of South Carolina·JournalJournal of Clinical and Translational Science·DateOct 29, 2025

UT Health San Antonio recognized among nation’s top 100 oncology programs

The Mays Cancer Center stands among the nation's leading institutions recognized for excellence in cancer care and research. It is one of only four NCI-designated Cancer Centers in Texas, offering specialized programs and delivering comprehensive, multidisciplinary care supported by clinical research.

SourceThe University of Texas at San Antonio Health Science Center·DateOct 28, 2025
Garmin GPSMAP 67i with inReach

Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.

FAU Engineering researchers make great ‘strides’ in gait analysis technology

Researchers at FAU Engineering have developed foot-mounted wearable sensors and a 3D depth camera that accurately measure how people walk, even in busy clinical environments. The study findings reveal that these technologies match the accuracy of traditional tools but are more scalable, remote, and cost-effective.

SourceFlorida Atlantic University·JournalSensors·TypeObservational study·DateOct 23, 2025

Researchers highlight ethical concerns when clinical trials are cut short

The termination of thousands of federal grants has raised ethical concerns about clinical trial closures, particularly among children and adolescents. Researchers argue that sudden stops can break trust and harm participants, violating long-standing principles.

SourceBoston University School of Public Health·JournalPEDIATRICS·TypeCommentary/editorial·DateOct 22, 2025

Targeted immunotherapy combination offers hope to older adults with leukemia

Researchers found a targeted immunotherapy regimen yielded promising survival outcomes for patients with B-cell ALL, outperforming historical results. The treatment was well-tolerated, with more than half completing the full course of therapy, and responded similarly in patients with complex medical histories.

SourceAlliance for Clinical Trials in Oncology·JournalJournal of Clinical Oncology·TypeRandomized controlled/clinical trial·DateOct 20, 2025
AmScope B120C-5M Compound Microscope

AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.

How multiple sclerosis harms a brain long before symptoms appear

Scientists analyzed thousands of proteins in blood samples to understand when multiple sclerosis attacks the myelin sheath and nerve fibers. Researchers identified a protein called IL-3, which plays a key role in this early phase of damage.

SourceUniversity of California - San Francisco·JournalNature Medicine·DateOct 20, 2025

Missing molecule may explain Down syndrome

Scientists found a promising candidate, pleiotrophin, which is essential for brain development and function; restoring it may improve brain circuits in individuals with Down syndrome and other neurological diseases. The study's findings suggest using modified viruses to deliver the protein directly into cells could lead to new treatments.

SourceUniversity of Virginia Health System·JournalCell Reports·DateOct 17, 2025

Discrimination experiences among medical students

A cross-sectional study reveals that medical students with disabilities experience both general and race-based discrimination, as well as gender-based discrimination. The findings highlight the need to address these intersecting forms of discrimination in medical education.

SourceJAMA Network·JournalJAMA Network Open·DateOct 16, 2025
Apple iPad Pro 11-inch (M4)

Apple iPad Pro 11-inch (M4) runs demanding GIS, imaging, and annotation workflows on the go for surveys, briefings, and lab notebooks.

Alliance Global study challenges age-based treatment decisions in leukemia

A recent study published in Leukemia found that age-based classifications in acute myeloid leukemia (AML) treatment may be outdated. The research analyzed data from 2,823 adult AML patients, revealing nuanced age-related trends in genetic mutations and survival outcomes.

SourceAlliance for Clinical Trials in Oncology·JournalLeukemia·TypeRandomized controlled/clinical trial·DateOct 14, 2025

Boston Children’s receives a $35 million donation to accelerate development of therapeutic options for children with brain disorders through the Rosamund Stone Zander and Hansjoerg Wyss Translational Neuroscience Center

Boston Children's Hospital has received a $35 million donation from Hansjoerg Wyss to further its translational neuroscience research, focusing on rare brain disorders and intellectual disability. The gift will support clinical trials, fellowships, and pilot studies, aiming to develop new therapies for vulnerable children.

SourceBoston Children's Hospital·DateOct 14, 2025

Study finds early menopause is associated with increased risk of dementia

A new study found that entering menopause at an earlier age is associated with a higher risk of dementia. On the other hand, post-menopause hormone replacement therapy appears to lower the risk of dementia. The research involved over 1,300 women from the Framingham Heart Study and analyzed various factors related to brain aging.

SourceUniversity of Galway·TypeRandomized controlled/clinical trial·DateOct 14, 2025
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

New Alliance trial aims to improve outcomes in metastatic prostate cancer

The ASPIRE trial is a Phase III clinical study investigating whether adding chemotherapy to standard treatments can extend survival in men with advanced prostate cancer. The trial aims to determine the effectiveness of combining docetaxel with hormone therapy and apalutamide.

SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateOct 6, 2025

Topical cream calms chemotherapy side effects on the skin

A topical formulation has been shown to reduce the incidence of hand-foot neuropathy in cancer patients undergoing chemotherapy, improving quality of life. The cream, developed at UMH, acts directly on neurosensory pain receptors, reducing hypersensitivity and tolerance to chemotherapy.

SourceUniversidad Miguel Hernandez de Elche·JournalClinical & Translational Oncology·TypeRandomized controlled/clinical trial·DateOct 2, 2025

Can digital health tools help younger cancer survivors better predict future health risks?

A groundbreaking study enrolls 465 AYA cancer patients to test if chatbot technology and digital education tools increase uptake of genetic counseling and improve patient outcomes. The trial aims to address longstanding gaps in genetic services for AYAs aged 18-39, who often receive care with limited access to genetic specialists.

SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateSep 30, 2025
Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

C-Path names Colin Hill to board of directors

Colin Hill joins C-Path's Board of Directors with experience in AI, drug development, and translational acceleration. He aims to bring precision medicine focus to advance treatments worldwide.

SourceCritical Path Institute (C-Path)·DateSep 30, 2025
Kestrel 3000 Pocket Weather Meter

Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.

Study: Remote monitoring improves recovery from cancer surgery

A new study shows that remote perioperative monitoring significantly improves recovery for cancer surgery patients, with a 6% greater functional recovery rate by day 14 after surgery. The study also found fewer major complications and improved symptom management.

SourceUniversity of Miami Miller School of Medicine·Journalnpj Digital Medicine·DateSep 17, 2025

Leading cancer societies update clinical guideline on post-mastectomy radiation therapy

The American Society for Radiation Oncology, American Society of Clinical Oncology, and Society of Surgical Oncology jointly published a guideline outlining when post-mastectomy radiation therapy (PMRT) is appropriate based on new evidence. PMRT reduces cancer recurrence risk in patients with node-positive disease or high-risk features.

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·TypeSystematic review·DateSep 16, 2025
Creality K1 Max 3D Printer

Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.

Novel therapy for pet cats with head and neck cancers could help humans, too

A new class of targeted therapy showed promise in treating head and neck squamous cell carcinoma (HNSCC) in pet cats, with 35% of patients experiencing controlled disease. The drug, which targets the transcription factor STAT3, also raised levels of PD-1, a protein associated with an immune response to cancer.

SourceCell Press·JournalCancer Cell·TypeRandomized controlled/clinical trial·DateAug 28, 2025
Apple AirPods Pro (2nd Generation, USB-C)

Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.

Study points out that a synthetic molecule helps reduce visceral fat and improve sleep

A synthetic molecule called Pep19 has been shown to reduce visceral fat and improve sleep quality in overweight adults, with no side effects observed. The study involved 24 volunteers who took either a placebo or Pep19 in capsules, and found a 17% reduction in visceral fat and improved sleep quality in those who received the molecule.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalDiabetes/Metabolism Research and Reviews·DateAug 28, 2025